Key result
Phenelzine is linked to impaired standing BP response versus moclobemide, with ~83% lacking normal overshoot.
Why the study?
The differential effects of phenelzine and moclobemide treatments on cardiovascular reflexes and heart rate variability were not well characterized.
Does phenelzine compared to moclobemide alter cardiovascular reflexes and heart rate variability?
Cross-Sectional (n=35)
Open-label
Does phenelzine compared to moclobemide alter cardiovascular reflexes and heart rate variability?
Phenelzine treatment significantly impairs sympathetic cardiovascular reflexes, such as the orthostatic blood pressure response, when compared to moclobemide.
Answers are grounded in this paper and cite their sources.
Phenelzine may warrant greater orthostatic caution than moclobemide; leaves open need for prospective trials on MAOI reflex effects.
The effects of treatment with phenelzine (n = 15) and moclobemide (n = 20) on heart rate variability and cardiovascular responses to standing were examined using non-invasive beat-to-beat blood pressure (BP) monitoring in an open cross-sectional study. Phenelzine markedly impaired the BP response compared with moclobemide, with 83% vs 15% of patients lacking the normal initial BP overshoot (p < 0.01). BP recovery to supine levels was delayed (median time for diastolic BP 14.5 s after phenelzine vs 4.9 s after moclobemide; p < 0.002). Standing BP at 1 min and its change from supine levels were also significantly lower in the phenelzine group (delta diastolic BP 4 mmHg vs 15 mmHg; p < 0.001). Heart rate responses and variability were preserved and did not differ between treatments. These findings are consistent with impairment of sympathetic function but preservation of parasympathetic responses after phenelzine treatment.
No takes yet. Share an insight, caveat, or question.
Coupland et al. (1995) reported a cross-sectional. Phenelzine vs. Moclobemide was evaluated on Lacking normal initial blood pressure overshoot upon standing (p=<0.01). Phenelzine markedly impaired the blood pressure response to standing compared with moclobemide, with of patients lacking the normal initial BP overshoot.
Synapse has enriched 10 related papers. Consider them for comparative context: